Elicio Therapeutics aims for breakthrough treatment with ELI-002 in pancreatic cancer. Find out why ELTX stock may benefit ...

European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) ...

Albumin use in patients with septic shock who had kidney impairment was associated with increased RRT (OR, 2.37) and with in-hospital mortality (OR, 1.21). Caution is urged with early albumin use ...

Attribution (BY): Credit must be given to the creator. The binding ability of human serum albumin (HSA) on active pharmaceutical ingredients (APIs) is one of the most important parameters in the early ...